393 related articles for article (PubMed ID: 29906273)
1. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
[TBL] [Abstract][Full Text] [Related]
2. Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study.
McDonnell SL; Baggerly C; French CB; Baggerly LL; Garland CF; Gorham ED; Lappe JM; Heaney RP
PLoS One; 2016; 11(4):e0152441. PubMed ID: 27049526
[TBL] [Abstract][Full Text] [Related]
3. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
Bilinski K; Boyages J
Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
[TBL] [Abstract][Full Text] [Related]
4. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study.
Vrieling A; Hein R; Abbas S; Schneeweiss A; Flesch-Janys D; Chang-Claude J
Breast Cancer Res; 2011 Jul; 13(4):R74. PubMed ID: 21791049
[TBL] [Abstract][Full Text] [Related]
5. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
[TBL] [Abstract][Full Text] [Related]
6. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
7. 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival.
Kanstrup C; Teilum D; Rejnmark L; Bigaard JV; Eiken P; Kroman N; Tjønneland A; Mejdahl MK
Breast Cancer Res Treat; 2020 Feb; 179(3):699-708. PubMed ID: 31707511
[TBL] [Abstract][Full Text] [Related]
8. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
[TBL] [Abstract][Full Text] [Related]
9. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
10. Calcium plus vitamin D supplementation and the risk of breast cancer.
Chlebowski RT; Johnson KC; Kooperberg C; Pettinger M; Wactawski-Wende J; Rohan T; Rossouw J; Lane D; O'Sullivan MJ; Yasmeen S; Hiatt RA; Shikany JM; Vitolins M; Khandekar J; Hubbell FA;
J Natl Cancer Inst; 2008 Nov; 100(22):1581-91. PubMed ID: 19001601
[TBL] [Abstract][Full Text] [Related]
11. Negative Impact of 25-hydroxyvitamin D Deficiency on Breast Cancer Survival.
Thanasitthichai S; Prasitthipayong A; Boonmark K; Purisa W; Guayraksa K
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3101-3106. PubMed ID: 31653160
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
Ginde AA; Scragg R; Schwartz RS; Camargo CA
J Am Geriatr Soc; 2009 Sep; 57(9):1595-603. PubMed ID: 19549021
[TBL] [Abstract][Full Text] [Related]
13. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.
Fedirko V; Torres-Mejía G; Ortega-Olvera C; Biessy C; Angeles-Llerenas A; Lazcano-Ponce E; Saldaña-Quiroz VA; Romieu I
Cancer Causes Control; 2012 Jul; 23(7):1149-62. PubMed ID: 22622862
[TBL] [Abstract][Full Text] [Related]
14. Determinants of Plasma 25-Hydroxyvitamin D Concentrations among Breast Cancer Survivors in Korea.
Shin WK; Kim Z; Youn HJ; Cho J; Lee JE
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29558405
[TBL] [Abstract][Full Text] [Related]
15. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study.
Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP
Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554
[TBL] [Abstract][Full Text] [Related]
16. The Association of Vitamin D Deficiency and Incident Frailty in Older Women: The Role of Cardiometabolic Diseases.
Buta B; Choudhury PP; Xue QL; Chaves P; Bandeen-Roche K; Shardell M; Semba RD; Walston J; Michos ED; Appel LJ; McAdams-DeMarco M; Gross A; Yasar S; Ferrucci L; Fried LP; Kalyani RR
J Am Geriatr Soc; 2017 Mar; 65(3):619-624. PubMed ID: 28008596
[TBL] [Abstract][Full Text] [Related]
17. Predicted 25-hydroxyvitamin D in relation to incidence of breast cancer in a large cohort of African American women.
Palmer JR; Gerlovin H; Bethea TN; Bertrand KA; Holick MF; Ruiz-Narvaez EN; Wise LA; Haddad SA; Adams-Campbell LL; Kaufman HW; Rosenberg L; Cozier YC
Breast Cancer Res; 2016 Aug; 18(1):86. PubMed ID: 27520657
[TBL] [Abstract][Full Text] [Related]
18. Serum 25-hydroxyvitamin d and cancer risk in older adults: results from a large German prospective cohort study.
Ordóñez-Mena JM; Schöttker B; Haug U; Müller H; Köhrle J; Schomburg L; Holleczek B; Brenner H
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):905-16. PubMed ID: 23462913
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D Supplementation Trials Aimed at Reducing Mortality Have Much Higher Power When Focusing on People with Low Serum 25-Hydroxyvitamin D Concentrations.
Brenner H; Jansen L; Saum KU; Holleczek B; Schöttker B
J Nutr; 2017 Jul; 147(7):1325-1333. PubMed ID: 28539415
[No Abstract] [Full Text] [Related]
20. Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort.
McCullough ML; Stevens VL; Patel R; Jacobs EJ; Bain EB; Horst RL; Gapstur SM; Thun MJ; Calle EE
Breast Cancer Res; 2009; 11(4):R64. PubMed ID: 19715600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
